Lundbeck Companies

Lundbeck is a pharmaceutical company that develops products to treat people with psychiatric and neurological disorders.

Last Funding Type: Grant
Funding Status: IPO
Headquarters: Valby, Hovedstaden, Denmark
Founded Date: 2000-01-01
Investor Type: Not Classified
Investment Stage: Undisclosed
Last Funding Date: 2020-03-04
Technology: Health Care, Health Diagnostics, Medical
Employee Number: 5001-10000
Number Of Exists: 1
Acquisitions Number: Made Acquisitions
Estimated Revenue: $500M to $1B
Investors Number: 1.0
Industry: Neurodegenerative disease diagnosis and treatment